Fulcrum Therapeutics (FULC) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 24, 2026, to be held virtually for stockholders of record as of April 27, 2026.

• Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request.

Voting matters and shareholder proposals

• Election of three Class I directors for three-year terms expiring at the 2029 annual meeting: Sonja Banks, Alan Ezekowitz, and Colin Hill.

• Non-binding advisory vote on executive compensation (say-on-pay).

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Provision for transaction of any other business that may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting for all director nominees and for all proposals on the agenda.